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Abstract
Background: Perfluorocarbon liquid (PFCL) is an effective surgical adjuvant in performing vitrectomy for severe
vitreoretinal pathologies such as proliferative vitreoretinopathy and giant retinal tears. However, subretinal retention
of PFCL can occur postoperatively and retained PFCL causes severe visual disorders, particularly when PFCL was
retained under the fovea. Although several procedures have been proposed for subfoveal PFCL removal, such as
direct aspiration or submacular injection of balanced salt solution (BSS) to dislodge the subfoveal PFCL, the retinal
damage associated with these procedures has been a major problem. Here, we report a case of subfoveal retention
of PFCL for which we performed a novel surgical technique that attempts to minimize retinal damage.
Case presentation: A 69-year-old man presented with subfoveal retained PFCL after surgery for retinal
detachment. To remove the retained PFCL, the internal limiting membrane overlying the subretinal injection site is
first peeled to allow low-pressure (8 psi) transretinal BSS infusion, using a 41-gauge cannula, to slowly detach the
macula. A small drainage retinotomy is created with the diathermy tip at the inferior position of the macular bleb,
sized to be slightly wider than that of the PFCL droplet. The head of the bed is then raised, and the surgeon gently
vibrates the patient’s head to release the PFCL droplet to allow it to migrate inferiorly towards the drainage
retinotomy. The bed is returned to the horizontal position, and the PFCL, now on the retinal surface, can be
aspirated. The subfoveal PFCL is removed while minimizing iatrogenic foveal and macular damage. One month
after PFCL removal, the foveal structure showed partial recovery on optical coherence tomography, and BCVA
improved to 20/40.
Conclusion: Creating a macular bleb with low infusion pressure and using vibrational forces and gravity to migrate
the PFCL towards a retinotomy can be considered as a relatively atraumatic technique to remove subfoveal
retained PFCL.
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Background
Perfluorocarbon liquid (PFCL) is an effective surgical ad-
juvant in performing vitrectomy for severe vitreoretinal
pathologies such as proliferative vitreoretinopathy and
giant retinal tears [1, 2]. However, subretinal retention
of PFCL can occur in 1–11% of cases [3, 4]. There may
be toxic effects on the retinal pigment epithelium (RPE)
and photoreceptors, [5] and retained PFCL can be visu-
ally significant, particularly when loculated under the
fovea [6].
Several procedures have been proposed for subfoveal
PFCL removal, including direct aspiration by using can-
nulas to puncture through the fovea [7]. This may lead
to scotomas and complications such as macular hole,
submacular hemorrhage, subfoveal choroidal neovascu-
larization, and submacular fibrosis due to photoreceptor
and RPE cell damage [7, 8]. Another reported technique
utilizes submacular injection of balanced salt solution
(BSS) to dislodge the subfoveal PFCL, with or without
extraction of the PFCL [9, 10]. This is likely less trau-
matic compared to the former technique, but forceful
submacular BSS injection can create macular holes and
photoreceptor damage if the injection pressure is high
[10–13]. Displacement of the subfoveal PFCL to the
extrafoveal area without aspiration of the PFCL requires
postoperative postural positioning, and the displaced
PFCL may migrate back to the fovea [6].
An atraumatic procedure for subfoveal PFCL removal
without the above limitations would therefore be benefi-
cial. Herein, we describe a novel surgical technique for
subfoveal PFCL removal that attempts to minimize
photoreceptor and RPE damage.
Case presentation
Presentation, history, and the initial surgery for retinal
detachment
A 69-year-old man presented with a temporal giant ret-
inal tear in the left eye with a macula-involving retinal
detachment. His best-corrected visual acuity (BCVA)
was 20/160 (Fig. 1a). We performed 25-gauge pars plana
vitrectomy with combined phacoemulsification. PFCL
was used to flatten the retina, but there was residual
subretinal fluid after PFCL removal, so a small drainage
retinotomy was created outside the arcade vessel at 6
o’clock to drain the remaining fluid, and photocoagula-
tion was performed, and 20% sulfur hexafluoride (SF6)
was used for tamponade.
The second surgery to remove subretinal PFCL droplets
On the first postoperative day, swept-source optical co-
herence tomography (OCT) obtained through the gas
bubble showed subretinal PFCL droplets, one of which
was retained under the fovea (Fig. 1b). We performed a
second surgery to remove the retained PFCL 5 days later.
Fig. 1 Preoperative and postoperative color fundus images and swept source optical coherence tomography. a A preoperative color fundus
image shows a retinal detachment with a temporal giant retinal tear (arrowheads). b Swept-source optical coherence tomography (OCT) B-scan
images obtained under intraocular gas on postoperative day 1 shows subretinal retention of two perfluorocarbon liquid (PFCL) droplets. The
droplet indicated by the arrow is located under the fovea; that indicated by the arrowhead is located in the parafoveal area. c Color fundus
image obtained 1month after PFCL removal. The retina is reattached. The arrow points to the drainage retinotomy created during the first
surgery, which was used to extract the subretinal PFCL droplets to the retinal surface. d OCT B-scan image obtained 1month after PFCL removal
shows resolution of the subretinal PFCL. The outer retinal microstructure of the fovea is not completely restored, but visual acuity was
20/40 (arrow)
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Four subretinal PFCL droplets were identified intraoper-
atively. Of these, two extrafoveal droplets were removed
by direct aspiration with a 41-gauge cannula. For re-
moval of the subfoveal and parafoveal PFCL, we created
a macular detachment via subretinal BSS injection at 8
psi, such that the area of the detachment included both
the PFCL droplets and the previous retinotomy, which
was conveniently created at the inferior position during
the first surgery. The head of the bed was elevated, and
the patient’s head was carefully vibrated for 10 s. The
subfoveal PFCL released onto the retinal surface and
was removed. Subsequently, we confirmed that the sec-
ond, parafoveal, droplet was still subretinally retained by
applying PFCL on the retinal surface to better delineate
its spherical shape. The same maneuver was repeated,
which released the second droplet. Fluid–air exchange,
retinopexy, and air–20% SF6 gas exchange were per-
formed (see Additional file 1).
Post-operative recovery of the macula
One month after PFCL removal, the foveal structure
showed partial recovery on OCT, and BCVA improved
to 20/40 (Fig. 1d). OCT of the area of the macular bleb
showed no anatomic damage to the photoreceptors and
RPE (Fig. 2).
Detailed explanation of surgical technique for subfoveal
PFCL removal
The first step is to create a submacular bleb with BSS. In
order to minimize the injection pressure of the BSS to
avoid diffuse photoreceptor and RPE damage, the in-
ternal limiting membrane (ILM) at the subretinal injec-
tion site can be focally peeled before placement of the
cannula (Fig. 3a, e) [11–13]. BSS is inserted into the Vis-
cous Fluid Control system (VFC; Alcon Laboratories,
Fort Worth, TX), which is connected to a 41-gauge can-
nula (MedOne, Sarasota, FL). The cannula is placed at
the ILM opening, and foot pedal control is used to
transfuse the BSS at a low injection pressure of 8 psi
through the retina (without having to penetrate
through), to create a submacular BSS bleb (Fig. 3b, f). By
pre-peeling the ILM, the BSS can permeate through the
neurosensory retina into the subretinal space, even with-
out puncturing through with the cannula tip. The macu-
lar detachment should extend across the posterior pole
beyond the arcade vessels, especially inferiorly. Subse-
quently, a small drainage retinotomy is created with a
diameter slightly larger than that of the PFCL droplet at the
inferior edge of the bleb, outside of the arcades (Fig. 3c, g).
The infusion line is then clamped, and removed from the
self-sealing cannula. All cannulas are inspected to be water-
tight. The head of the patient’s bed is then raised from su-
pine to upright position, while ensuring that vitrectomy
unit cords and anesthesia-related apparatuses are not com-
promised. With the head now elevated, the height of the
macular detachment inferior to the PFCL increases due to
gravitational forces (Fig. 3h). The surgeon then carefully
vibrates the patient’s head manually for approximately
10 s to release the PFCL from the subfoveal position,
which then finds its way out of the inferior drainage
Fig. 2 Subretinal injection of balanced salt solution (BSS) and postoperative optical coherence tomography (OCT). a An intraoperative image
demonstrating the initiation of subretinal infusion of BSS using a 41G cannula (arrow) (Additional file 1). The arrowheads indicate the border of
the bleb. The white line corresponds to the OCT scan in (b). The yellow and black arrowheads indicate the subfoveal and parafoveal PFCL
droplets, respectively. b OCT image scanned at the horizontal line in Fig. a, 1 month after PFCL removal. The outer retinal structure is
continuous (arrows)
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retinotomy (Fig. 3d, h). The patient is returned to the
supine position, and the PFCL droplet on the retinal
surface is aspirated. This is followed by fluid–air ex-
change and photocoagulation around the drainage reti-
notomy. At the end of the surgery, air is replaced with
20% SF6 gas (see Additional file 2).
Discussion and conclusions
We describe a new surgical technique to remove subfo-
veally retained PFCL, with the goal of minimizing theor-
etical iatrogenic effects to the foveal and macular outer
retina. Several observations were made during this
procedure.
In order to displace the PFCL droplets, we created a
macular detachment with BSS and encountered two
phenomena. First, although the macular detachment was
easily created over the PFCL droplet in the parafoveal
area, it could not be extended above the subfoveal drop-
let (Fig. 4a, b; Additional file 1). A possible reason is that
the retinal tissue in contact with the PFCL droplets dif-
fered between the subfoveal and parafoveal droplets. As
shown in Figs. 1 and 4, the parafoveal PFCL stays mostly
within the outer retina, whereas the subfoveal PFCL is
draped by very thin tissue [14]. The inner retinal layers
are absent at the fovea, except Müller cell cones. There-
fore, we speculate that the interface between the PFCL
and thinner foveal tissue may be stronger than the extra-
foveal photoreceptors. This adhesive force, whether it
may be mechanical from the draping by the thin foveal
tissue, and/or a vacuum-like state from surface tension,
prevented BSS from flowing above the subfoveal PFCL.
On the other hand, there were no significant adhesive
forces between the extrafoveal PFCL and outer retina,
which permitted easy separation. To create macular de-
tachments over subfoveal PFCL, the subretinal injection
is required to be performed at a pressure so that the
force of injected BSS flow becomes greater than the in-
traocular pressure multiplied by the area of adhesion be-
tween the subfoveal PFCL and fovea (Fig. 4i). The
intraocular pressure can therefore be lowered to facili-
tate this step.
Second, the injection pressure (8 psi) alone failed in
displacing both the subfoveal and parafoveal PFCL drop-
lets. To release the droplets from the RPE, we utilized
gravity and vibration to mobilize the subretinal PFCL
(Fig. 4g, h; Additional files 1 and 2). To utilize gravity,
just as the rotation of surgical table during vitrectomy
for giant retinal tear, [15, 16] we thought that it was ef-
fective to change the patient’s position from supine to
upright by moving the head of the patient’s bed. When
moving the head of the patient’s bed, care should be
taken to ensure that infusion and anesthesia lines are se-
cure and the patient should be strapped securely de-
pending on the method of anesthesia and the patient’s
physical attributes. The vibration should be gentle
enough not to cause iatrogenic complications, and not
recommended in young children, elderly patients, or
anyone with intracranial or cervical susceptibilities, and
Fig. 3 Schematic of a novel surgical technique for subfoveal perfluorocarbon liquid (PFCL) removal. e, f, g, and h show vertical cross-sections of
a, b, c, and d, respectively. The black arrowheads indicate the local of the PFCL droplet. a and e The internal limiting membrane at the site for
subretinal injection of BSS (cross mark). b and f Subretinal bleb (asterisk) is induced by subretinal BSS injection using a 41-gauge cannula (white
arrowhead) at a pressure of 8 psi. c and g An small drainage retinotomy (arrow) is created at the inferior end of the bleb (asterisk). d and h The
patient’s position is changed from supine to upright. When the patient is placed in the upright position, the subretinally injected BSS gathers
inferiorly from gravity, while the height of the retinal detachment below the PFCL droplet increases (double headed arrow). Then, the head is
vibrated by the surgeon to facilitate migration of the subfoveal PFCL to the retinal surface through the retinotomy.
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intubation would be a contraindication. Patients under-
going vitreoretinal surgery in Japan often receive local
anesthesia without any systemic anesthetics, and are
fully alert. This may not be the practice pattern in many
settings, in which case raising the head of the bed may
not be safe. Furthermore, not all surgical beds have the
ability to raise the patient’s head upright. In such set-
tings, we recommend temporal drainage retinotomies,
and tilting the head temporally to use the same princi-
ples. The bleb should be large enough, and retinotomy
far temporal enough, to assure that a scotoma does not
develop. Tilting the chin up and head reclined further
with a superior retinotomy may be an option also.
Whichever procedure is chosen, the number of head tilts
and shakes should be minimized to avoid discomfort to
the patient.
Creation of the submacular bleb is a key component
of this procedure. Prior peeling of the ILM (which ac-
counts for half of retinal stiffness [17]) at the subretinal
injection site allows transretinal infusion of BSS into the
subretinal space using a low injection pressure (6–8 psi),
even without the cannula puncturing through the retina
[11, 12]. We confirmed in non-human primate eyes that
8 psi prevents diffuse photoreceptor and RPE damage
that may accompany subretinal injections at higher infu-
sion pressures [13]. Consistent with these data, we were
Fig. 4 Subfoveal perfluorocarbon (PFCL) liquid is adherent to the fovea during macular bleb creation. a Intraoperative image prior to creation of
the macular bleb. The black and white arrowheads indicate the subfoveal and parafoveal PFCL droplets, respectively. b Intraoperative image after
the creation of the macular bleb. The area of macular detachment includes both PFCL droplets. The retina was easily lifted off the parafoveal
PFCL (white arrowhead) with the bleb creation, and the outline of the parafoveal PFCL droplet is now more obscured compared to Fig. a.
However, the retina does not lift off the subfoveal PFCL (black arrowhead). The outline of the subfoveal droplet remains well delineated. c
Schematic of subfoveal PFCL (black arrowhead), showing possible contact with the internal limiting membrane (ILM) via compressed or separate
Müller cell cones. d On the other hand, the parafoveal PFCL (white arrowhead) appears to stay well beneath the outer retina and may make
contact with the inner retinal layer, but not the ILM. e The arrows indicate the flow of the injected BSS. At the fovea, BSS does not significantly
flow between the PFCL (black arrowhead) and the retina due to adhesion between the two. f However, at the parafoveal area, BSS flows easily
between the PFCL (white arrowhead) and the retina, as shown by the arrow (f). g When the patient is repositioned vertically, the subretinally
injected BSS gathers inferiorly, while the height of the retinal detachment inferior to the PFCL increases (double headed arrow). h Vibrational
forces (gray arrow) break the adhesion between the PFCL and the retina (arrowhead). This causes the PFCL droplet to migrate inferiorly (arrow). i
Adhesion between the surface of the subfoveal PFCL and Müller cell cones/ILM. To break this adhesion, a force greater than the intraocular
pressure (arrows) multiplied by the area of the adhesion (red line) is required
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likely able to minimize cellular damage to the macula
(Fig. 2b).
In conclusion, we present a novel surgical technique
utilizing focal ILM peeling, subretinal BSS, gravity, and vi-
brational forces to release and extract subfoveally retained
PFCL. Since the retained subfoveal PFCL may have toxic
effects on the RPE and photoreceptors, [5] the PFCL
should be removed as soon as its existence is identified.
Future studies would be warranted to generate more effi-
cacy and safety data, as well as to expand our understand-
ing of manipulations in the submacular space with
modern instrumentation and surgical techniques.
Patient perspective
The patient was content with the improvement of vision
in the left eye, which has allowed him to continue his
daily activities.
Supplementary information
Supplementary information accompanies this paper at https://doi.org/10.
1186/s12886-020-01698-1.
Additional file 1 Surgical video of subfoveal perfluorocarbon liquid
removal using subretinal balanced salt solution, vibrational forces, and
gravity.
Additional file 2 Animation of a novel surgical technique for subfoveal
perfluorocarbon liquid removal using subretinal balanced salt solution,
vibrational forces, and gravity.
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